---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-27T10:39:14.955669'
end_time: '2025-12-27T10:46:27.375350'
duration_seconds: 432.42
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: KCTD8
  gene_symbol: KCTD8
  uniprot_accession: Q6ZWB6
  protein_description: 'RecName: Full=BTB/POZ domain-containing protein KCTD8;'
  gene_info: Name=KCTD8;
  organism_full: Homo sapiens (Human).
  protein_family: Not specified in UniProt
  protein_domains: BTB/POZ_dom. (IPR000210); H1_KCTD8. (IPR049904); SKP1/BTB/POZ_sf.
    (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 25
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q6ZWB6
- **Protein Description:** RecName: Full=BTB/POZ domain-containing protein KCTD8;
- **Gene Information:** Name=KCTD8;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** BTB/POZ_dom. (IPR000210); H1_KCTD8. (IPR049904); SKP1/BTB/POZ_sf. (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "KCTD8" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'KCTD8' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **KCTD8** (gene ID: KCTD8, UniProt: Q6ZWB6) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q6ZWB6
- **Protein Description:** RecName: Full=BTB/POZ domain-containing protein KCTD8;
- **Gene Information:** Name=KCTD8;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** BTB/POZ_dom. (IPR000210); H1_KCTD8. (IPR049904); SKP1/BTB/POZ_sf. (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "KCTD8" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'KCTD8' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **KCTD8** (gene ID: KCTD8, UniProt: Q6ZWB6) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive research report: Human KCTD8 (UniProt Q6ZWB6)

Identity verification and core concepts
- Target verified: KCTD8 (BTB/POZ domain-containing protein KCTD8) is a human KCTD-family protein with an N‑terminal BTB/POZ (also termed T1-type) oligomerization domain and C‑terminal homology region(s) found among GABAB auxiliary KCTDs. Foundational brain proteomics identified KCTD8 as a native interactor of GABAB receptors, consolidating its classification as an auxiliary subunit of GABABRs (Homo sapiens orthology inferred across mammalian systems). The BTB/POZ identity of KCTD8 is explicitly documented among native GABAB receptor complexes purified from brain (Nature 2010) (schwenk2010nativegababreceptors pages 13-16). High-resolution studies of KCTD subfamily members (KCTD16, KCTD12) define the shared domain architecture and conserved binding interfaces with GB2 applicable to KCTD8 by sequence and structural conservation (Nature 2019; PNAS 2019) (zheng2019structuralbasisfor pages 1-2, zuo2019structuralbasisfor pages 1-1).

- Family/domain features: GABAB-associated KCTDs (KCTD8/12/12b/16) possess: (1) an N-terminal BTB/T1 oligomerization domain that binds the GABAB2 (GB2) intracellular C-terminus; and (2) a downstream H1 domain that binds Gβγ; KCTD8/KCTD16 additionally retain a distal H2 domain absent in KCTD12/12b, which underlies their distinct desensitization behavior (inferred from structural/functional comparisons across KCTDs) (Nature 2019; PNAS 2019) (zheng2019structuralbasisfor pages 1-2, zuo2019structuralbasisfor pages 1-1).

Primary function and mechanisms
- Role as GABAB receptor auxiliary subunit: Native GABAB receptors are heteromultimers with auxiliary KCTDs; KCTD8 co-purifies with GABAB1/2 from brain, establishing it as part of receptor complexes in situ (Nature 2010; URL: https://doi.org/10.1038/nature08964; published May 13, 2010) (schwenk2010nativegababreceptors pages 13-16).
- Receptor and G protein binding sites: Structural work shows KCTDs form asymmetric pentamers via the BTB domain that wrap around a GB2 C-terminal peptide; the GB2–KCTD interface is conserved across KCTD8/12/16, implying the same mode for KCTD8. The H1 domain symmetrically engages five Gβγ copies, with cooperative binding that underlies kinetic control of signaling (Nature 2019; URL: https://doi.org/10.1038/s41586-019-0990-0; published Feb 27, 2019) (zheng2019structuralbasisfor pages 1-2). The KCTD16–GB2 crystal structure further delineates the BTB pentamer binding a single GB2 CTD peptide, with interface residues conserved among KCTDs and required for GABAB/GIRK modulation (PNAS 2019; URL: https://doi.org/10.1073/pnas.1903024116; published Apr 16, 2019) (zuo2019structuralbasisfor pages 1-1).
- Signaling kinetics and GIRK coupling: KCTD family members shape rise times and desensitization of GABAB-evoked GIRK currents; KCTD proteins bind Gβγ and can rapidly strip G proteins from GIRKs to induce desensitization. KCTD12/12b harbor an H1 desensitization motif, whereas KCTD8 (and KCTD16) lack this motif and thus support comparatively non-desensitizing or slowly desensitizing responses; collectively, KCTD8/12/16 set distinct activation/desensitization kinetics of GIRK and the overall time course of GABAB signaling (Nature 2019) (zheng2019structuralbasisfor pages 1-2). Earlier mechanistic physiology established that KCTD8/12/16 constitutively interact with G proteins to stabilize them at the receptor and accelerate K+ current responses (Neuron 2014; URL: https://doi.org/10.1016/j.neuron.2014.04.015; published Jun 4, 2014) (david2018gababreceptorassociatedkctd pages 14-17).

Subcellular localization and expression patterns
- Presynaptic enrichment in habenula pathway: In mouse medial habenula (MHb) cholinergic neurons projecting to the interpeduncular nucleus (IPN), KCTD8 shows presynaptic active-zone localization with GABAB1 and Cav2.3 channels. Active-zone replica labeling demonstrated KCTD8 presence within Cav2.3/GABAB1-positive zones; genetic perturbations established functional contribution to basal release probability (eLife 2021; URL: https://doi.org/10.7554/eLife.68274; published Apr 14, 2021) (bhandari2021gababreceptorauxiliary pages 9-11). Immunohistochemistry in the same circuit showed strong KCTD8 expression in somata and axonal terminals of ChAT+ habenula neurons (J. Neurosci. 2022; URL: https://doi.org/10.1523/JNEUROSCI.1676-21.2021; published Jan 19, 2022) (ren2022kctd8andkctd12 pages 7-9).
- Axonal GABAB receptor enrichment: Genetic deletion of KCTD8/12/16 (triple KO) reduced axonal GABAB receptor expression in habenular cholinergic terminals without affecting somatic receptors, indicating a role for KCTD8/12 in presynaptic axonal targeting/stability of GABABRs (J. Neurosci. 2022) (ren2022kctd8andkctd12 pages 7-9).

Interactions beyond canonical GABAB coupling
- Cav2.3 channel association: In the MHb→IPN pathway, KCTD8 directly binds Cav2.3 and modulates its currents in heterologous cells; at synapses, KCTD8 co-clusters with Cav2.3 and GABAB1. Functionally, KCTD8 KO decreased basal release probability (WT: 0.26 ± 0.04 vs Kctd8−/−: 0.12 ± 0.02; n = 16 and 12 cells, respectively), whereas KCTD8 overexpression lowered PPR (EGFP: 2.17 ± 0.18 vs LV-KCTD8: 1.41 ± 0.14), consistent with enhanced release probability when KCTD8 is present (eLife 2021) (bhandari2021gababreceptorauxiliary pages 9-11).
- Potential Cul3–E3 ligase linkage (cautious inference): BTB-containing KCTDs often act as substrate adaptors for Cullin3 E3 ubiquitin ligases; family-level evidence strongly supports Cul3 engagement (e.g., KCTD5/Cul3–Gβγ). For KCTD8 specifically, direct Cul3 biochemical evidence remains limited; the domain architecture and family context suggest plausibility that remains to be established experimentally (family overview and mechanistic model in 2018 thesis) (david2018gababreceptorassociatedkctd pages 14-17). Given the lack of direct KCTD8–Cul3 evidence here, this remains an inference rather than a demonstrated property.

Quantitative signaling data (selected)
- Presynaptic GABAB excitation requires KCTD8/12: In MHb cholinergic axons, triple KOs (Kctd8/12/16) showed substantially reduced baclofen-induced potentiation of glutamate release (−67.3% of fold increase vs wild-type) and smaller increases in presynaptic Ca2+ entry (−36.6% vs wild-type), linking KCTD8/12/16 to the magnitude and duration of presynaptic GABAB excitation (J. Neurosci. 2022) (ren2022kctd8andkctd12 pages 7-9).
- Basal release probability and PPR shifts: At MHb terminals, Kctd8−/− reduced release probability to 0.12 ± 0.02 (WT 0.26 ± 0.04), while KCTD8 overexpression decreased PPR from 2.17 ± 0.18 (control) to 1.41 ± 0.14, reflecting increased release probability with KCTD8 (eLife 2021) (bhandari2021gababreceptorauxiliary pages 9-11).

Recent developments and expert analyses (2021–2024 emphasis)
- Structural mechanism generalized to KCTD8: Cryo-EM/X-ray studies (2019) elucidated that KCTD BTB pentamers encircle a GB2 tail and that H1 pentamers bind Gβγ cooperatively, mechanistically explaining accelerated activation and desensitization control. Conservation across KCTD8/12/16 supports application of this mechanism to KCTD8 (Nature 2019; PNAS 2019) (zheng2019structuralbasisfor pages 1-2, zuo2019structuralbasisfor pages 1-1).
- Circuit-specific presynaptic roles: Multiple 2021–2022 studies in the habenulo–interpeduncular pathway uncovered KCTD8’s presynaptic localization and function, including direct Cav2.3 binding, modulation of release probability, and necessity for robust axonal GABAB receptor expression and presynaptic excitation (eLife 2021; J. Neurosci. 2022) (bhandari2021gababreceptorauxiliary pages 9-11, ren2022kctd8andkctd12 pages 7-9).
- Hetero-oligomerization within the KCTD family: KCTD proteins can form hetero-oligomers that confer distinct kinetics to GABAB signaling; while direct KCTD8-containing hetero-oligomer stoichiometries in human tissue remain to be quantified, the KCTD family’s ability to hetero-assemble is supported, with implications for signal diversification (IJMS 2023 review/primary dataset) (liao2023kctd5formsheterooligomeric pages 9-10).

Pathways and cellular context
- GABAB–GIRK axis: KCTD8 modulates GABAB coupling to GIRK channels by binding GB2 and Gβγ. Through cooperative Gβγ engagement, KCTDs regulate GIRK activation kinetics and desensitization. KCTD8’s lack of the canonical desensitization motif (present in KCTD12/12b) positions it toward less desensitizing/slowly desensitizing profiles, extending inhibitory postsynaptic signaling windows relative to KCTD12-driven complexes (Nature 2019) (zheng2019structuralbasisfor pages 1-2).
- Presynaptic Cav2.3 coupling and transmitter release: KCTD8 co-localizes with Cav2.3 at presynaptic active zones and tunes basal release probability and the time course of presynaptic GABAB-mediated facilitation, thereby shaping short-term plasticity in the MHb→IPN circuit (eLife 2021; J. Neurosci. 2022) (bhandari2021gababreceptorauxiliary pages 9-11, ren2022kctd8andkctd12 pages 7-9).

Disease associations and translational notes
- Neuropsychiatric links via GABAB/KCTD axis: Genetic and functional studies implicate the GABAB–KCTD module in neuropsychiatric phenotypes (e.g., mood disorders associated with KCTD12 and GABAB dysfunction). While direct human genetic associations specific to KCTD8 remain limited in the sources reviewed here, KCTD8 contributes to neural circuit functions (habenula) relevant to aversion and affective behaviors (Nature 2019 for family-level; J. Neurosci. 2022 for circuit-level) (zheng2019structuralbasisfor pages 1-2, ren2022kctd8andkctd12 pages 7-9). Further targeted human genetic studies for KCTD8 are warranted.

Oligomeric state
- KCTD BTB domains assemble into pentamers that scaffold GB2 and Gβγ; although solved for KCTD16, the conserved interfaces and cross-KCTD functional readouts strongly support a KCTD8 pentameric assembly at the receptor (Nature 2019; PNAS 2019) (zheng2019structuralbasisfor pages 1-2, zuo2019structuralbasisfor pages 1-1).

Cellular localization
- Cytosolic/inner membrane face auxiliary protein that associates with the intracellular tail of GB2 at the plasma membrane; enriched at presynaptic active zones in specific circuits (MHb→IPN), and also present in somata of the same cholinergic neurons (eLife 2021; J. Neurosci. 2022) (bhandari2021gababreceptorauxiliary pages 9-11, ren2022kctd8andkctd12 pages 7-9).

Expert opinions and synthesis
- Structural and functional convergence argues that KCTD8 serves as a timing element for GABAB signaling: its BTB-mediated GB2 binding tethers a KCTD8 pentamer at the receptor, while its H1 domain engages Gβγ to set activation rise times and desensitization. The presence of a distal H2 region and absence of the KCTD12 desensitization motif rationalize KCTD8’s more sustained signaling profile. Circuit studies extend KCTD8’s role from postsynaptic GIRK regulation to presynaptic release control via Cav2.3 coupling and axonal GABAB receptor enrichment, highlighting KCTD8 as a modular regulator of both inhibitory and excitatory outputs downstream of GABABRs (Nature 2019; PNAS 2019; eLife 2021; J. Neurosci. 2022) (zheng2019structuralbasisfor pages 1-2, zuo2019structuralbasisfor pages 1-1, bhandari2021gababreceptorauxiliary pages 9-11, ren2022kctd8andkctd12 pages 7-9).

Real-world applications and implementations
- Targeting GB2–KCTD interfaces: The structurally defined GB2–KCTD interface offers a druggable surface for modulating GABAB kinetics selectively (PNAS 2019) (zuo2019structuralbasisfor pages 1-1).
- Circuit-selective modulation: Given KCTD8’s presynaptic enrichment and Cav2.3 interactions in the habenula–IPN pathway, KCTD8 represents a handle for circuit-specific tuning of aversion-related behaviors, with potential relevance to mood and addiction treatments (eLife 2021; J. Neurosci. 2022) (bhandari2021gababreceptorauxiliary pages 9-11, ren2022kctd8andkctd12 pages 7-9).

Limitations and open questions
- Direct biochemical confirmation of KCTD8–Cul3 binding and ubiquitin E3 activity remains to be established, despite strong family precedent for BTB–Cul3 adaptors; current evidence for KCTD8 is inferential (david2018gababreceptorassociatedkctd pages 14-17).
- Human tissue-level expression atlases and single-cell resolution datasets for KCTD8 were not directly captured in the sources cited here; more comprehensive transcriptomic/proteomic profiling in human brain would refine localization and disease associations.

Key references with URLs and publication dates
- Native GABAB heteromultimers with KCTDs (includes KCTD8): Nature, May 13, 2010. URL: https://doi.org/10.1038/nature08964 (schwenk2010nativegababreceptors pages 13-16).
- Structural mechanism for KCTD-mediated GABAB control (conserved across KCTD8/12/16): Nature, Feb 27, 2019. URL: https://doi.org/10.1038/s41586-019-0990-0 (zheng2019structuralbasisfor pages 1-2).
- GB2–KCTD16 structure defining a druggable interface, conserved features applicable to KCTD8: PNAS, Apr 16, 2019. URL: https://doi.org/10.1073/pnas.1903024116 (zuo2019structuralbasisfor pages 1-1).
- Presynaptic active-zone localization with Cav2.3, quantitative release modulation by KCTD8: eLife, Apr 14, 2021. URL: https://doi.org/10.7554/eLife.68274 (bhandari2021gababreceptorauxiliary pages 9-11).
- KCTD8/12/16 facilitate axonal GABAB receptor expression and presynaptic excitation: Journal of Neuroscience, Jan 19, 2022. URL: https://doi.org/10.1523/JNEUROSCI.1676-21.2021 (ren2022kctd8andkctd12 pages 7-9).
- Mechanistic physiology of KCTD-dependent acceleration/desensitization via G protein stabilization at GABAB: Neuron, Jun 4, 2014. URL: https://doi.org/10.1016/j.neuron.2014.04.015 (david2018gababreceptorassociatedkctd pages 14-17).
- KCTD5 hetero-oligomerization with neuronal KCTDs (family-level heteromers relevant to KCTD8): IJMS, Sep 18, 2023. URL: https://doi.org/10.3390/ijms241814317 (liao2023kctd5formsheterooligomeric pages 9-10).

Conclusion
Human KCTD8 (Q6ZWB6) is a BTB/POZ-domain KCTD that functions as an auxiliary GABAB receptor subunit. Through a conserved BTB-mediated GB2 interaction and H1-mediated cooperative Gβγ binding, it shapes the activation and desensitization kinetics of GABAB signaling, particularly coupling to GIRK. In defined brain circuits, KCTD8 is enriched at presynaptic active zones, binds Cav2.3, and governs basal release probability and the strength/duration of presynaptic GABAB-mediated excitation. Structural frameworks generalize from solved KCTD12/16 complexes to KCTD8 based on conservation, and recent circuit studies position KCTD8 as a tunable node for synaptic and behavioral modulation. Direct evidence for a KCTD8–Cul3 E3 ligase role remains an open area for investigation (schwenk2010nativegababreceptors pages 13-16, zheng2019structuralbasisfor pages 1-2, zuo2019structuralbasisfor pages 1-1, bhandari2021gababreceptorauxiliary pages 9-11, ren2022kctd8andkctd12 pages 7-9, david2018gababreceptorassociatedkctd pages 14-17, liao2023kctd5formsheterooligomeric pages 9-10).

References

1. (schwenk2010nativegababreceptors pages 13-16): Jochen Schwenk, Michaela Metz, Gerd Zolles, Rostislav Turecek, Thorsten Fritzius, Wolfgang Bildl, Etsuko Tarusawa, Akos Kulik, Andreas Unger, Klara Ivankova, Riad Seddik, Jim Y. Tiao, Mathieu Rajalu, Johana Trojanova, Volker Rohde, Martin Gassmann, Uwe Schulte, Bernd Fakler, and Bernhard Bettler. Native gabab receptors are heteromultimers with a family of auxiliary subunits. Nature, 465:231-235, May 2010. URL: https://doi.org/10.1038/nature08964, doi:10.1038/nature08964. This article has 377 citations and is from a highest quality peer-reviewed journal.

2. (zheng2019structuralbasisfor pages 1-2): Sanduo Zheng, Nohely Abreu, Joshua Levitz, and Andrew C. Kruse. Structural basis for kctd-mediated rapid desensitization of gabab signalling. Nature, 567:127-131, Feb 2019. URL: https://doi.org/10.1038/s41586-019-0990-0, doi:10.1038/s41586-019-0990-0. This article has 97 citations and is from a highest quality peer-reviewed journal.

3. (zuo2019structuralbasisfor pages 1-1): Hao Zuo, Ian Glaaser, Yulin Zhao, Igor Kurinov, Lidia Mosyak, Haonan Wang, Jonathan Liu, Jinseo Park, Aurel Frangaj, Emmanuel Sturchler, Ming Zhou, Patricia McDonald, Yong Geng, Paul A. Slesinger, and Qing R. Fan. Structural basis for auxiliary subunit kctd16 regulation of the gabab receptor. Proceedings of the National Academy of Sciences, 116:8370-8379, Apr 2019. URL: https://doi.org/10.1073/pnas.1903024116, doi:10.1073/pnas.1903024116. This article has 54 citations and is from a highest quality peer-reviewed journal.

4. (david2018gababreceptorassociatedkctd pages 14-17): David Berner. Gabab receptor-associated kctd proteins as molecular linkers to downstream signaling complexes. ArXiv, 2018. URL: https://doi.org/10.5451/unibas-006803142, doi:10.5451/unibas-006803142. This article has 0 citations.

5. (bhandari2021gababreceptorauxiliary pages 9-11): Pradeep Bhandari, David Vandael, Diego Fernández-Fernández, Thorsten Fritzius, David Kleindienst, Cihan Önal, Jacqueline Montanaro, Martin Gassmann, Peter Jonas, Akos Kulik, Bernhard Bettler, Ryuichi Shigemoto, and Peter Koppensteiner. Gabab receptor auxiliary subunits modulate cav2.3-mediated release from medial habenula terminals. eLife, Apr 2021. URL: https://doi.org/10.7554/elife.68274, doi:10.7554/elife.68274. This article has 29 citations and is from a domain leading peer-reviewed journal.

6. (ren2022kctd8andkctd12 pages 7-9): Yuqi Ren, Yang Liu, Sanduo Zheng, and Minmin Luo. Kctd8 and kctd12 facilitate axonal expression of gaba<sub>b</sub>receptors in habenula cholinergic neurons. The Journal of Neuroscience, 42:1648-1665, Jan 2022. URL: https://doi.org/10.1523/jneurosci.1676-21.2021, doi:10.1523/jneurosci.1676-21.2021. This article has 11 citations.

7. (liao2023kctd5formsheterooligomeric pages 9-10): Yini Liao, Douglas C. Sloan, Josephine H. Widjaja, and Brian S. Muntean. Kctd5 forms hetero-oligomeric complexes with various members of the kctd protein family. International Journal of Molecular Sciences, 24:14317, Sep 2023. URL: https://doi.org/10.3390/ijms241814317, doi:10.3390/ijms241814317. This article has 9 citations and is from a poor quality or predatory journal.

## Citations

1. schwenk2010nativegababreceptors pages 13-16
2. zheng2019structuralbasisfor pages 1-2
3. zuo2019structuralbasisfor pages 1-1
4. david2018gababreceptorassociatedkctd pages 14-17
5. bhandari2021gababreceptorauxiliary pages 9-11
6. https://doi.org/10.1038/nature08964;
7. https://doi.org/10.1038/s41586-019-0990-0;
8. https://doi.org/10.1073/pnas.1903024116;
9. https://doi.org/10.1016/j.neuron.2014.04.015;
10. https://doi.org/10.7554/eLife.68274;
11. https://doi.org/10.1523/JNEUROSCI.1676-21.2021;
12. https://doi.org/10.1038/nature08964
13. https://doi.org/10.1038/s41586-019-0990-0
14. https://doi.org/10.1073/pnas.1903024116
15. https://doi.org/10.7554/eLife.68274
16. https://doi.org/10.1523/JNEUROSCI.1676-21.2021
17. https://doi.org/10.1016/j.neuron.2014.04.015
18. https://doi.org/10.3390/ijms241814317
19. https://doi.org/10.1038/nature08964,
20. https://doi.org/10.1038/s41586-019-0990-0,
21. https://doi.org/10.1073/pnas.1903024116,
22. https://doi.org/10.5451/unibas-006803142,
23. https://doi.org/10.7554/elife.68274,
24. https://doi.org/10.1523/jneurosci.1676-21.2021,
25. https://doi.org/10.3390/ijms241814317,